Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2004-08-13
2008-10-21
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C424S184100, C424S248100
Reexamination Certificate
active
07439041
ABSTRACT:
Peptide reagents that interact preferentially with the PrPscform of the prion protein are described. Methods of using the reagents or antibodies to the reagents for detection, diagnosis, purification, therapy and prophylaxis for prions and prion-associated diseases are also described.
REFERENCES:
patent: 6211149 (2001-04-01), Chesebro et al.
patent: 6372214 (2002-04-01), Prusiner et al.
patent: 6462171 (2002-10-01), Soto-Jara et al.
patent: 6656716 (2003-12-01), Plowman et al.
patent: 6680170 (2004-01-01), Plowman et al.
patent: 6765088 (2004-07-01), Korth et al.
patent: 2003/0166558 (2003-09-01), Frangione et al.
patent: 2004/0186273 (2004-09-01), Hammond et al.
patent: 2004/0208919 (2004-10-01), Nicolau et al.
patent: 2005/0100962 (2005-05-01), van Oers et al.
patent: 2006/0057671 (2006-03-01), Orser
patent: 0 909 388 (2003-09-01), None
patent: 1 457 500 (2004-09-01), None
patent: WO 93/11155 (1993-06-01), None
patent: WO 93/23432 (1993-11-01), None
patent: WO 97/16728 (1997-05-01), None
patent: WO 99/15651 (1999-04-01), None
patent: WO 00/29849 (2000-05-01), None
patent: WO 00/43791 (2000-07-01), None
patent: WO 00/78344 (2000-12-01), None
patent: WO 01/07479 (2001-02-01), None
patent: WO 01/35104 (2001-05-01), None
patent: WO 01/77687 (2001-10-01), None
patent: WO 01/97785 (2001-12-01), None
patent: WO 02/04954 (2002-01-01), None
patent: WO 02/065134 (2002-08-01), None
patent: WO 02/097444 (2002-12-01), None
patent: WO 03/045128 (2003-06-01), None
patent: WO 03/050139 (2003-06-01), None
patent: WO 03/073106 (2003-09-01), None
patent: WO 03/085086 (2003-10-01), None
patent: WO 2004/005920 (2004-01-01), None
patent: WO 2004/018511 (2004-03-01), None
patent: WO 2004/029072 (2004-04-01), None
patent: WO 2004/091523 (2004-04-01), None
patent: WO 2004/037854 (2004-05-01), None
patent: WO 2004/046728 (2004-06-01), None
patent: WO 2004/050851 (2004-06-01), None
patent: WO 2004/090102 (2004-10-01), None
patent: WO 2006/026977 (2006-03-01), None
Bienkiewicz et al. J. Mo. Biol., 2000, vol. 297, p. 119-133.
Lee et al. Cell, 1996, vol. 85, p. 931-942.
Georgieva, Experimantal pathology and parasitology, 2002, p. 60-63.
Coulthart et al. CMAJ, 2001, vol. 165, p. 51-58.
Irani et al. Annu. rev. Med., 2003, vol. 54, p. 305-319.
Koller et al., “Induction of antibodies against murine full-length prion protein in wild-type mice,” Journal of Neuroimmunology 132:113-116 (2002).
Gasset et al., “Predicted α-Helical Regions of the Prion Protein When Synthesized as Peptides Form Amyloid”Proc. Natl. Acad. Sci.USA (1992) 89:10940-10944.
Nguyen et al., “Prion Protein Peptides Induce α-Helix to β-Sheet Conformational Transitions”Biochemistry(1995) 34:4186-4192.
Peretz et al., “A Conformational Transition at the N Terminus of the Prion Protein Features in Formation of the Scrapie Isoform”J. Mol. Biol.(1997) 273:614-622.
Peretz et al., “Antibodies Inhibit Prion Propagation and Clear Cell Cultures of Prion Infectivity”Nature(2001) 412:739-743.
Priola, “Prion Protein Diversity and Disease in the Transmissible Spongiform Encephalopathies”Advances in Protein Chemistry(2001) 57:1-27.
Ryou et al., “Differential Inhibition of Prion Propagation By Enantiomers of Quinacrine”Laboratory Investigation(2003) 83:837-843.
Tagliavini et al., “Synthetic Peptides Homologous to Prion Protein Residues 106-147 Form Amyloid-Like Fibrils in vitro”Proc. Natl. Acad. Sci. USA(1993) 90:9678-9682.
Tagliavini et al.“Studies on Peptide Fragments of Prion Proteins”Advances in Protein Chemistry(2001) 57:171-201.
Williamson et al., “Mapping the Prion Protein Using Recombinant Antibodies”Journal of Virology(1998) 72:9413-9418.
Hu Celine Y-H.
Michelitsch Melissa D.
Boesen Agnieszka
Campell Bruce R.
Lillis Marcella
Novartis Vaccines and Diagnostics Inc.
Pasternak Dahna S.
LandOfFree
Prion-specific peptide reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prion-specific peptide reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prion-specific peptide reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4007669